Taking a bold step into the world of bundled payment models can help an organization transform itself, but it could fail.
Organizations that want to change are not the same as organizations that are willing to change. It takes a bold leader to make recommendations that may be new and uncomfortable to the organization. As consultants who analyze complex data on a daily basis, we’re constantly steering our clients to make decisions—including some that may be well outside of their comfort zone. The trend toward more mandatory bundled payment models from CMS will be a forcing function that pushes organizations to make bold decisions and transform their businesses—or fail.
Voluntary models like BPCI-Advanced (BPCI-A), the successor to Bundled Payments for Care Improvement, should be viewed as a sandbox to prepare for this future of mandatory alternative payment models. Now is the time to raise the bar on what’s comfortable — and keep raising it. Now is the time to be bold.
We are passionate about using bundled payment models as innovative solutions for business transformation. Participation can lead to improved quality outcomes and patient/provider satisfaction while lowering costs, and using these models will prepare organizations for the future of value-based care.
Here are 4 things to think about when analyzing whether BPCI-A is right for your organization:
Give your organization a leg up in the value-based care environment of tomorrow by moving boldly towards this change today. More mandatory bundled payment models are coming, so it makes sense to the experience you need to effect positive change. BPCI-A can be a great means to decrease readmissions, length of stay, and post-acute utilization while improving internal cost savings, patient/provider satisfaction, and achieving CMS savings. If that sounds good, ask yourself these 3 questions: Do you want to change? Are you willing to change? Are you willing to lead boldly?
Author Information
Darcie Hurteau, MBA, is senior director, DataGen. Tamara Cull, DHA, is senior vice president, Aveus.
About Aveus
The Aveus team offers 20 years of experience in providing strategic consulting, operational and advisory services, value-based program design, integrated care management models, and innovation implementation.
About DataGen
DataGen is an essential partner to healthcare organizations across the country, illustrating the financial implications of payment policy changes and promoting a pragmatic view of how changes will affect revenue and profitability.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
April 18th 2024Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
April 18th 2024Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Read More
2 Commerce Drive
Cranbury, NJ 08512